Clinical Trials Browser

Phase 3 × Neoplasm Metastasis × 3-Iodobenzylguanidine × Clear all

NCT00037869 2018-10-31

High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors

Phase 3 Completed

Neoplasm Metastasis, Neuroendocrine Tumors